Bacterial Skin Infection Antibiotic Approved by FDA

10:34 EDT 20 Jun 2017 | PharmPro

Melinta Therapeutics announces U.S. FDA approval of Baxdela™ (delafloxacin) for acute bacterial skin and skin structure infections (ABSSSI).
Contributed Author: 
Globe Newswire

Original Article: Bacterial Skin Infection Antibiotic Approved by FDA


More From BioPortfolio on "Bacterial Skin Infection Antibiotic Approved by FDA"

Quick Search


Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Acne Dermatology Eczema Psoriasis Wound Care Dermatology is the medical specialty concerned with the diagnosis and treatment of skin disorders (Oxford Medical Dictionary). As well as studying how the skin works, dermatology covers...

Wound management
Anything that breaks the skin is a wound because when the skin is broken, there's a risk of germs getting into the body and causing an infection. Follow and track Wound Care News on BioPortfolio: Wound Car...